Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/10/2026 | 1,910 | 0.0% | 32,134 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,442 | 0.0% | 26,621 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 1,485 | 0.0% | 27,021 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 934 | 0.0% | 13,218 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 854 | 0.0% | 12,986 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 1,021 | 0.0% | 14,527 | 9/30/2024 |
| 2024 Q2 | 8/16/2024 | 32,509 | 0.0% | 394,860 | 6/30/2024 |
| 2024 Q1 | 5/15/2024 | 49,118 | 0.1% | 562,376 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 50,169 | 0.1% | 520,313 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 41,476 | 0.1% | 468,763 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 37,675 | 0.0% | 434,643 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 37,997 | 0.1% | 390,756 | 3/31/2023 |
| 2022 Q4 | 2/21/2023 | 15,691 | 0.0% | 151,621 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 11,675 | 0.0% | 137,730 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 5,847 | 0.0% | 70,551 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 5,317 | 0.0% | 68,953 | 3/31/2022 |
| 2021 Q4 | 2/3/2022 | 915 | 0.0% | 10,359 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 872 | 0.0% | 11,275 | 9/30/2021 |
| 2021 Q2 | 8/13/2021 | 748 | 0.0% | 8,962 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 684 | 0.0% | 9,058 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 775 | 0.0% | 8,849 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 391 | 0.0% | 5,139 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 346 | 0.0% | 2,808 | 6/30/2020 |
| 2020 Q1 | 5/8/2020 | 139 | 0.0% | 1,644 | 3/31/2020 |
| 2019 Q4 | 2/13/2020 | 129 | 0.0% | 1,523 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 80 | 0.0% | 1,289 | 6/30/2014 |
| 2014 Q1 | 5/15/2014 | 102 | 0.0% | 1,506 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 26 | 0.0% | 374 | 12/31/2013 |